Iron deficiency in pregnancy: Effects on the newborn

Current Opinion in Hematology

Volumn 6, Issue 2, 1999, Pages 65-70

  Blot, Isa ^a   Diallo, Dapa ^b   Tchernia, Gil ^a  

^a BICÊTRE HOSPITAL   (France)

^b Malaria Research and Training Center   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON;

HUMAN; IRON DEFICIENCY; IRON INTAKE; IRON STORAGE; IRON THERAPY; MATERNAL NUTRITION; PREGNANCY; PRIORITY JOURNAL; REVIEW; THIRD TRIMESTER PREGNANCY;

ANEMIA, IRON-DEFICIENCY; DIETARY SUPPLEMENTS; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; IRON; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE;

EID: 0032813134     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199903000-00002     Document Type: Review

References (54)

1. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA 1997, 277:973-976.
2. Vulpe C, Gitschier J: Ironing out anaemia. Nat Genet 1997, 16:319-320.
3. Centers for Disease Control and Prevention: Recommendations to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998, 47(RR-3):1-29. This report is a detailed overview of prevalence of, screening for, and prevention of iron deficiency in the United States.
4. Bodmer JG, Parham P, Albert ED, Marsh SGE: Putting a hold on "HLA-H." Nat Genet 1997, 15:234-235.
5. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, et al.: HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 1998, 95:2492-2497. To test the hypothesis that the HFE gene, which had been identified as a candidate gene for hereditary hemochromatosis, was responsible for the disease, the effects of a targeted disruption of the murine homologue of the HFE gene were studied. HFE-deficient mice exhibit iron overload: HFE protein is involved in the regulation of iron homeostasis. The murine model provides opportunities to evaluate therapeutic strategies for the prevention or correction of iron overload.
6. Theil E: Iron regulatory elements (IREs): a family of mRNA non coding sequences. Biochem J 1994, 304:1-11.
7. Klausner RD, Rouault TA, Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 1993, 72:19-28.
8. Fleming MD, Trenor III CC, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrew NC: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997, 16:383-386. Homozygous mk/mk mice have microcytic hypochromic anemia as a result of severe defects in intestinal absorption and erythroid iron utilization. The authors of this study have identified a strong candidate gene for mk and suggest that the phenotype is a consequence of a missense mutation in Nramp2, a previously identified gene of unknown function. This finding has implications for our understanding of iron transport.
9. Andrews NC, Fleming MD, Levy JE: Molecular insights into mechanisms of iron transport. Curr Opin Hematol 1999, 6:61-64.
10. Fenton C, Cavill J, Fisher J: Iron stores in pregnancy. Br J Haematol 1977, 37:145-149.
11. Barrett JFR, Whittaker PG, Williams JG, Lind T: Absorption of non-haem iron from food during normal pregnancy. Br Med J 1994, 309:79-82.
12. Taylor DJ, Mallen C, McDougall N, Lind T: Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol 1982, 89:1011-1017.
13. Matoth Y, Zaizov R: Factors affecting materno-fetal transfer of iron in the rat. Biol Neonate 1977, 32:43-46.
14. Glasser SR, Wright C, Heyssel RM: Transfer of iron across the placenta and fetal membranes in the rat. Am J Physiol 1968, 215:205-209.
15. Singla PN, Gupta VK, Agarwal KN: Storage iron in human foetal organs. Acta Paediatr Scand 1985, 74:701-706.
16. Galbraith GMP, Galbraith RM, Temple A, Faulk WP: Demonstration of transferrin receptors on human placental trophoblast. Blood 1980, 55:240-245.
17. Vanderpuye OA, Kelley LK, Smith CH: Transferrin receptor in the basal plasma membrane of the human placental syncytiotrophoblast. Placenta 1986, 7:391-403.
18. Okuyama T, Tawada T, Furuya H, Villee C: The role of transferrin and ferritin in the fetal-maternal-placental unit. Am J Obstet Gynecol 1985, 152:344-350.
19. Starreveld JS, Kroos MJ, Van Suijlen JDE, Verrijt CEH, Van Eijk HG, Van Dijk JP: Ferritin in cultured human cytotrophoblasts: synthesis and subunit distribution. Placenta 1995, 16:383-395.
20. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, et al.: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 1997, 94:198-202.
21. Kuiper-Kramer EP, Baerts W, Bakker R, Van Eyck J, Van Raan J, Van Eijk HC: Evaluation of the iron status of the newborn by soluble transferrin receptors in serum. Clin Chem Lab Med 1998, 36:17-21.
22. Tchernia G, Archambeaud MP, Yvart J, Diallo D: Erythrocyte ferritin in human neonate: maternofetal iron kinetics revisited. Clin Lab Haematol 1996, 18:147-153.
23. Theil EC: The abundance of ferritin in yolk-sac derived red blood cells of embryonic mouse. Br J Haematol 1976, 33:437-442.
24. Valaitis A, Theil EC: Developmental changes in plasma transferrin concentration related to red cell ferritin. J Biol Chem 1984, 259:779-784.
25. Robinson S, Godfrey K, Denne J, Cox V: The determinants of iron status in early pregnancy. Br J Nutr 1998, 79:249-255.
26. Galan P, Yoon HC, Preziosi P, Viteri F, Valeix P, Fieux B, et al.: Determining factors in the iron status of adult women in the SU.VI.MAX study. Eur J Clin Nutr 1998, 52:383-388.
27. World Health Organization: The prevalence of anaemia in women. Geneva: World Health Organization; 1992.
28. Dop MC, Blot I, Dyck JL, Assimadi K, Hodonou AKS, Doh A: L'anémie à l'accouchement à Lomé (Togo): prévalence, facteurs de risque et répercussions chez le nouveau-né. Rev Epidemiol Santé Publique 1992, 40:259-267.
29. Fleming AF: Anaemia in pregnancy in tropical Africa. Trans R Soc Trop Med Hyg 1989, 83:441-448.
30. Hercberg S, Chauliac M, Devanlay M, Galan P, Christides JP, Potier de Courcy C, et al.: Evaluation of the iron status of a rural population in South Benin. Nutr Res 1986, 6:627-634.
31. Bothwell TH: Overview and mechanisms of iron regulation. Nutr Rev 1995, 53:237-245.
32. Oski FA: Iron deficiency in infancy and childhood. N Engl J Med 1993, 329:190-193.
33. Rios E, Lipschitz DDA, Cook JD, Smith NJ: Relationship of maternal and infant iron stores as assessed by determination of plasma ferritin. Pediatrics 1975, 55:694-699.
34. Blot I, Tchernla G, Chenayer M, Hill C, Hajeri H, Leluc R: La carence martiale chez la femme enceinte. Etude de son retentissement chez le nouveau-né. Influence d'un traitement martial systématique. J Gynecol Obstet Biol Reprod (Paris) 1980, 9:489-495.
35. Hussain MA, Gaatar TH, Laulicht M, Hoffbrand AV: Relation of maternal and cord blood serum ferritin. Arch Dis Child 1977, 52:782-784.
36. Milman N, Ibsen KK, Christensen JM: Serum ferritin and iron status in mothers and newborn infants. Acta Obstet Gynecol Scand 1987, 6:205-211.
37. Kelly AM, MacDonald DJ, McDougall AN: Ferritin as an assessment of iron stores in normal pregnancy. Br J Obstet Gynaecol 1978, 85:338-343.
38. Singla PN, Tyagi M, Shankar R, Dash D, Kumar A: Fetal iron status in maternal anemia. Acta Paediatr 1996, 85:1327-1330.
39. Lubin AH, Bonner JL, Shrock RO: Effect of maternal iron status on the subsequent development of iron deficiency in the infant. J Pediatr 1980, 96:1114-1115.
40. Colomer J, Colomer C, Gutierrez D, Jubert A, Nolasco A, Donat J, et al.: Anemia during pregnancy as a risk factor for infant iron deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) study. Paediatr Perinat Epidemiol 1990, 4:196-204.
41. Preziosi P, Prual A, Galan P, Douada H, Boueima H, Hercberg S: Effect of iron supplementation on the iron status of pregnant women: consequences for newborns. Am J Clin Nutr 1997, 66:1178-1182.
42. Morton RE, Nysenbaum A, Price K: Iron status in the first year of life. J Pediatr Gastroenterol Nutr 1988, 7:707-712.
43. Diallo D, Sidibé H, Diakité S, Doumbia S, Yvart J, Tchernia G: Prévalence de l'anémie du nouveau-né au Mali. Cah Sante 1994, 4:341-345.
44. Schultink W, Van Der Ree M, Matulessi P, Gross R: Low compliance with an iron-supplementation program: a study among pregnant women in Jakarta, Indonesia. Am J Clin Nutr 1993, 57:135-139.
45. Foulkes J, Goldie DJ: The use of ferritin to assess the need for iron supplements in pregnancy. J Obstet Gynecol 1982, 3:11-16.
46. Viteri FE: Iron supplementation for the control of iron deficiency in populations at risk. Nutr Rev 1997, 55:195-209. This elegant review evaluates the practice of iron supplementation and emphasizes the importance of community involvement and a preventive orientation in iron supplementation programs. The authors develop the concept of "preventive supplementation," aimed at ensuring adequate iron nutrition throughout a woman's life cycle, and they propose the use of weekly doses, which are almost free of side effects and lead to better adherence than daily doses.
47. Viteri FE, Liu X-N, Tolomei K, Martin A: The absorption and retention of supplemental iron is more efficient when administered every three days rather than daily to iron-normal or iron-deficient rats. J Nutr 1995, 125:82-91.
48. Hallberg L: Combating iron deficiency: daily administration of iron is far superior to weekly administration. Am J Clin Nutr 1998, 68:213-217. This controversial paper argues against the weekly administration of iron during pregnancy and favors the classic daily administration. Clear evidence that a mucosal block reduces the efficacy of daily iron therapy is lacking, and the side effects of daily doses have not been established on a scientific basis. A primary challenge in iron supplementation programs is to improve compliance.
49. Liu X, Yang W, Song Y: Evaluation of the effects of intermittent iron supplement on iron-deficiency anemia in children. Chin J Prevent Med 1995, 29:34-37.
50. Ridwan D, Schultink W, Dillon D, Gross R: Effects of weekly iron supplementation on pregnant Indonesian women are similar to those of daily supplementation. Am J Clin Nutr 1996, 63:884-890.
51. Roodenburg AJC: Iron supplementation during pregnancy. Eur J Obstet Gynecol Reprod Biol 1995, 61:65-71.
52. Institute of Medicine, Food and Nutrition Board: Iron deficiency anemia: guidelines for prevention, detection and management among US children and women of childbearing age. Washington: National Academy Press; 1993.
53. Eskeland B, Malterud K, Ulvik RJ, Hunskaar S: Iron supplementation in pregnancy: is less enough? A randomized, placebo controlled trial of low dose iron supplementation with and without heme iron. Acta Obstet Gynecol Scand 1997, 76:822-828.
54. Menendez C, Todd J, Alonso PL, Francis N, Lulat S, Ceesay S, et al.: The effect of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg 1994, 88:590-593.